# Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

> **NCT05963334** · PHASE1,PHASE2 · COMPLETED · sponsor: **Cairo University** · enrollment: 49 (actual)

## Conditions studied

- Advanced Epithelial Ovarian Cancer

## Interventions

- **DRUG:** Carboplatin/paclitaxel

## Key facts

- **NCT ID:** NCT05963334
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2019-11-30
- **Final completion:** 2023-06-06
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2023-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05963334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05963334, "Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05963334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*